Secretive US Trade Deal Could Endanger Global Health Gains

Much of the concern focuses on a host of provisions that would impact the ability of poor communities to get cheap generic medicines.

Carey L. Biron
By Carey L. Biron

WASHINGTON --- As a major free trade agreement nears the end of negotiations, the United States appears to be doubling down and even strengthening its demands for restrictive new provisions that public health advocates warn would significantly curtail access to affordable medicines and health care in developing countries. Internal documents

Read Full Article

Obamacare Fails To Address High Drug Prices

The ACA’s implementation will see few of the prescription drug reforms Barack Obama once promised.

Katie Rucke
By Katie Rucke

With the implementation of the Affordable Care Act, the price of prescription drugs, including generic ones, may not be as affordable as some Americans had anticipated or hoped. Though originally touted as a piece of legislation that would grant U.S. consumers access to safe and affordable drugs, heavy lobbying by Big Pharma -- specifically the

Read Full Article

Ill-Gotten Gains: Big Pharma’s Sick Hold On Doctors And The Health Care Economy

Patients’ needs compete with the dancing dollar signs in their physicians’ heads.

Edward Rhymes
By Edward Rhymes

Pharmaceutical companies’ grip on the practice of medicine and healthcare is near absolute. From its influence over medical students to the bribing of their generic drug-making competition, Big Pharma has shown that making more money is preferable to making more people well.   Educate to disseminate A study published in the Journal of

Read Full Article

Supreme Court: Big Pharma’s Paying To Delay Generic Drugs Can Be Challenged In Courts

Drug companies had hoped the court to would immunize their agreements, which keep cheaper forms of medicine off the market.

Associated Press
By Associated Press
Prescription drugs line a cabinet in this March 25, 2011 photo. (Photo by Eric Hunsaker via Flikr)

WASHINGTON — Deals between pharmaceutical corporations and their generic drug competitors, which government officials say keep cheaper forms of medicine off the market, can sometimes be illegal and therefore can be challenged in court, the Supreme Court said Monday. The justices voted 5-3 to allow the government to inspect and challenge what it

Read Full Article